← Back to Search

Reading Tutoring for Executive Function Development in Children

N/A
Recruiting
Led By Laurie E Cutting, PhD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children in Kindergarten (approximate ages 4-9 years)
Native English speakers
Must not have
Children not in Kindergarten at time of enrollment
Known intelligence quotient (IQ) below 70
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, at study entry (fall of kindergarten); and approximately 1 year after baseline (fall of 1st grade)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how well reading, math, and executive function skills interact in young children's brains to predict academic outcomes.

Who is the study for?
This trial is for Kindergarten children, approximately ages 4-9, who are native English speakers. It's not suitable for kids with intellectual disabilities, uncorrectable vision or significant hearing loss, metal devices that preclude MRI scans, IQ below 70, neurological issues like epilepsy or brain tumors, severe psychiatric disorders or those on certain psychotropic meds.
What is being tested?
The study examines how brain networks related to reading skills and executive functions (EF) interact in young children. By following participants from Kindergarten through 1st grade, the research aims to predict academic outcomes and see how well they respond to reading tutoring interventions.
What are the potential side effects?
Since this trial involves educational interventions such as reading tutoring rather than medical treatments or drugs, there are no direct physical side effects expected. However, participation may involve time commitment and potential stress associated with testing environments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is in Kindergarten, aged between 4-9 years.
Select...
I am a native English speaker.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child is not yet in Kindergarten.
Select...
My IQ is below 70.
Select...
I have a known brain or nerve condition such as epilepsy or cerebral palsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, at study entry (fall of kindergarten); and approximately 1 year after baseline (fall of 1st grade)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, at study entry (fall of kindergarten); and approximately 1 year after baseline (fall of 1st grade) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Woodcock Johnson Tests of Achievement, Fourth Edition (WJ-IV)
Woodcock Johnson Tests of Achievement, Fourth Edition (WJ-IV)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Reading Tutoring InterventionActive Control1 Intervention
20 hours of one-on-one reading tutoring administered over 6 weeks
Group II: Business as UsualActive Control1 Intervention
Instruction as usual within schools

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
710 Previous Clinical Trials
6,143,120 Total Patients Enrolled
4 Trials studying Dyslexia
1,109 Patients Enrolled for Dyslexia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,284 Total Patients Enrolled
10 Trials studying Dyslexia
5,834 Patients Enrolled for Dyslexia
Laurie E Cutting, PhDPrincipal InvestigatorVanderbilt University

Media Library

Reading Tutoring Clinical Trial Eligibility Overview. Trial Name: NCT03713125 — N/A
Dyslexia Research Study Groups: Reading Tutoring Intervention, Business as Usual
Dyslexia Clinical Trial 2023: Reading Tutoring Highlights & Side Effects. Trial Name: NCT03713125 — N/A
Reading Tutoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT03713125 — N/A
~26 spots leftby Jul 2025